This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1980 Oct 25;281(6248):1143-4.

doi: 10.1136/bmj.281.6248.1143-a.

Can insulin-treated diabetics be given beta-adrenergic-blocking drugs?

U Smith, G Blohmé, I Lager, P Lönnroth

PMID: 6107166
PMCID: PMC1714602
DOI: 10.1136/bmj.281.6248.1143-a

Can insulin-treated diabetics be given beta-adrenergic-blocking drugs?

U Smith et al. Br Med J. 1980.

. 1980 Oct 25;281(6248):1143-4.

doi: 10.1136/bmj.281.6248.1143-a.

Authors

U Smith, G Blohmé, I Lager, P Lönnroth

PMID: 6107166
PMCID: PMC1714602
DOI: 10.1136/bmj.281.6248.1143-a

No abstract available

PubMed Disclaimer

Similar articles

[Beta receptor blocking agents, insulin and hypoglycemia].
Froland A. Froland A. Ugeskr Laeger. 1976 Nov 15;138(47):2970. Ugeskr Laeger. 1976. PMID: 10661 Danish. No abstract available.
Can insulin-treated diabetics be given beta-adrenergic blocking drugs?
Barnett AH, Leslie D, Watkins PJ. Barnett AH, et al. Br Med J. 1980 Apr 5;280(6219):976-8. doi: 10.1136/bmj.280.6219.976. Br Med J. 1980. PMID: 6106521 Free PMC article.
Beta blockers for diabetics.
[No authors listed] [No authors listed] Lancet. 1977 Apr 16;1(8016):843. Lancet. 1977. PMID: 67346 No abstract available.
Beta-blockers, diabetes, and hypoglycemia: risky business?
Levinson PD. Levinson PD. Med Health R I. 2001 Mar;84(3):81-2. Med Health R I. 2001. PMID: 11280134 Review. No abstract available.
Metabolic effects of antihypertensive treatment with beta-blockers.
Sawicki PT, Berger M. Sawicki PT, et al. J Intern Med Suppl. 1991;735:97-9. J Intern Med Suppl. 1991. PMID: 1675055 Review.

See all similar articles

Cited by

Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.
Kerr D, MacDonald IA, Heller SR, Tattersall RB. Kerr D, et al. Br J Clin Pharmacol. 1990 Jun;29(6):685-93. doi: 10.1111/j.1365-2125.1990.tb03689.x. Br J Clin Pharmacol. 1990. PMID: 1974143 Free PMC article. Clinical Trial.
Adverse effects of exogenous insulin. Clinical features, management and prevention.
Patrick AW, Williams G. Patrick AW, et al. Drug Saf. 1993 Jun;8(6):427-44. doi: 10.2165/00002018-199308060-00004. Drug Saf. 1993. PMID: 8329148 Review.
Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
Plosker GL, Clissold SP. Plosker GL, et al. Drugs. 1992 Mar;43(3):382-414. doi: 10.2165/00003495-199243030-00006. Drugs. 1992. PMID: 1374320 Review.
Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.
Peters DH, Benfield P. Peters DH, et al. Pharmacoeconomics. 1994 Oct;6(4):370-400. doi: 10.2165/00019053-199406040-00004. Pharmacoeconomics. 1994. PMID: 10147474 Review.

References

1. Lancet. 1975 May 31;1(7918):1213-5 - PubMed
1. Br Med J. 1976 Jul 31;2(6030):272-3 - PubMed
1. Scott Med J. 1977 Jan;22(1):69-72 - PubMed
1. Br Med J. 1977 Nov 12;2(6097):1255-7 - PubMed
1. Lancet. 1979 Mar 3;1(8114):458-62 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Medical
- MedlinePlus Health Information